High Prevalence of Faecal Carriage of ESBL-Producing Enterobacteriaceae Among Children in Dar Es Salaam, Tanzania
Overview
Authors
Affiliations
Background: Faecal carriage of ESBL-producing bacteria is a potential risk for transmission and infection. Little is known about faecal carriage of antibiotic resistance in Tanzania. This study aimed to investigate the prevalence of faecal carriage of ESBL-producing Enterobacteriaceae and to identify risk factors for carriage among young children in Tanzania.
Methodology/principal Findings: From August 2010 to July 2011, children below 2 years of age were recruited in Dar es Salaam, including healthy community children (n = 250) and children hospitalized due to diarrhoea (n = 250) or other diseases (n = 103). ChromID ESBL agar and ChromID CARBA SMART agar were used for screening. Antimicrobial susceptibility testing was performed by the disk diffusion method. ESBL genotypes were identified by Real-Time PCR and sequencing. The overall prevalence of ESBL carriage was 34.3% (207/ 603). The prevalence of ESBL carriage was significantly higher among hospitalized children (50.4%), compared to community children (11.6%; P < 0.001; OR = 7.75; 95% CI: 4.99-12.03). We found high prevalence of Multidrug-resistance (94%) among Escherichia coli and Klebsiella pneumoniae isolates. No resistance to carbapenems was detected. For the majority of isolates (94.7%) we detected a blaCTX-M-15-like gene. In addition, the plasmid mediated AmpC beta-lactamase CMY-2 was detected for the first time in Tanzania. ESBL prevalence was significantly higher among HIV positive (89.7%) than HIV negative (16.9%) children (P = 0.001; OR = 9.99; 95% CI: 2.52-39.57). Use of antibiotics during the past 14 days and age below 1 year was also associated with ESBL carriage.
Conclusions/significance: We report a high rate of faecal carriage of ESBL-producing Enterobacteriaceae among children below 2 years of age in Tanzania, particularly those with HIV-infection. Resistance to a majority of the available antimicrobials commonly used for children in Tanzania leaves few treatment options for infections when caused by these bacteria.
Garba Z, Bonkoungou I, Somda N, Natama M, Some G, Sangare L BMC Infect Dis. 2025; 25(1):109.
PMID: 39849346 PMC: 11760080. DOI: 10.1186/s12879-025-10506-4.
Macha M, Qi W, Seiffert S, Bosch A, Kohler P, Urassa H Front Microbiol. 2025; 15():1517182.
PMID: 39834365 PMC: 11743186. DOI: 10.3389/fmicb.2024.1517182.
Muhummed A, Alemu A, Hosch S, Osman Y, Tschopp R, Yersin S Antimicrob Resist Infect Control. 2024; 13(1):148.
PMID: 39695886 PMC: 11656975. DOI: 10.1186/s13756-024-01502-5.
Befikadu D, Tamrat R, Garedo A, Beyene G, Gudina E, Gashaw M BMC Microbiol. 2024; 24(1):459.
PMID: 39506640 PMC: 11539523. DOI: 10.1186/s12866-024-03596-8.
Paediatric Enterobacteriaceae infections in hospitalised children in Durban, KwaZulu-Natal.
Krishinchand H, Naidoo K, Mahabeer P, Archary M S Afr J Infect Dis. 2024; 36(1):279.
PMID: 39376941 PMC: 11457515. DOI: 10.4102/sajid.v36i1.279.